Abvc Biopharma (ABVC) Intangibles (2011 - 2026)

Abvc Biopharma's (ABVC) quarterly Intangibles came in at $64594.0 in Q4 2015, little changed on a QoQ basis from $64594.0 in Q3 2015.

Abvc Biopharma (ABVC) Intangibles (2011 - 2026) Analysis & Trends

Abvc Biopharma (ABVC) has 3 years of Intangibles data on file, last reported at $64594.0 in Q4 2015.

Quarterly Intangibles changed N/A year-over-year to $64594.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $64594.0 (changed N/A YoY) and the FY2015 annual result came in at $64594.0, changed N/A from the prior year.
Intangibles steadied at $64594.0 in Q4 2015, from $64594.0 in the prior quarter.
In the past five years, Intangibles ranged from a high of $202630.0 in Q2 2012 to a low of $64594.0 in Q3 2015.
A 3-year average of $132683.2 and a median of $131754.5 in 2011 frame the typical range for Intangibles.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Intangibles (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	412.80 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	1.31 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	266.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	60.96 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	93.49 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Abvc Biopharma	23.19 Mn	23.19 Mn	-	3.50 Mn

Download Data